Ten years of induced pluripotency: from basic mechanisms to therapeutic applications.
Ten years ago, the discovery that mature somatic cells could be reprogrammed into induced pluripotent stem cells (iPSCs) redefined the stem cell field and brought about a wealth of opportunities for both basic research and clinical applications. To celebrate the tenth anniversary of the discovery, the International Society for Stem Cell Research (ISSCR) and Center for iPS Cell Research and Application (CiRA), Kyoto University, together held the symposium 'Pluripotency: From Basic Science to Therapeutic Applications' in Kyoto, Japan. The three days of lectures examined both the mechanisms and therapeutic applications of iPSC reprogramming. Here we summarize the main findings reported, which are testament to how far the field has come in only a decade, as well as the enormous potential that iPSCs hold for the future.
Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
Peter
P
Karagiannis
Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan kojieto@cira.kyoto-u.ac.jp.
Koji
0000-0002-5863-7122
K
Eto
D000818:Animals; D002454:Cell Differentiation; D004194:Disease; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology* / Q000637:transplantation*; D033581:Stem Cell Transplantation
Cell reprogramming; Pluripotency; iPS cells